Abacus Group and Medicus IT, two leading providers of IT managed services with deep subject matter expertise in the highly ...

FFL Partners ("FFL"), a private equity firm focused on growth investments in tech-enabled business services and healthcare companies, today announced the completion of the merger of FFL portfolio ...

MSPs get to benefit from every important IT trend that comes along, whether that's cybersecurity or data and AI,' said FFL's ...

Medicus Pharma offers high-risk, high-reward potential, with its novel SkinJect patch for basal cell carcinoma and Antev ...

ASX 200 healthcare shares led the market last week, propelled by yet another share price surge for market darling Pro Medicus ...

In a world chasing passive giants, Australian small caps shine with active alpha, sector diversity, and next-gen growth ...

Pro Medicus (ASX: PME) won a contract with UCHealth of at least $170 million over 10 years, marking its second-largest ...

The Pro Medicus Ltd (ASX: PME) share price is racing higher today. Here’s why investors are piling into the ASX 200 ...

An exclusive deal announcement involving IT managed service providers; an outlook on the industrials and manufacturing M&A ...

Aussie shares marked a fresh record closing high on Tuesday, with healthcare and tech stocks powering the market forward. The ...

About Medicus Pharma Ltd: Medicus Pharma Ltd. (NASDAQ: MDCX) is a biotech/life sciences company focused on accelerating the clinical development programs of novel and disruptive therapeutics assets.

Whenever the healthcare imaging software group signs a new customer contract, fund managers hide under their desks. This latest one really hurts.